|

New sustained-release metformin tablets (Ⅲ) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • China National Center for Cardiovascular Diseases1

Indications

  • Atherosclerotic Heart Disease1
  • Heart Disease1
  • Diabetes1
  • Type 2 Diabetes1

Other1 trial

Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.